Moderate

Paediatric chronic asthma management

respiratory · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Long-term control of childhood asthma using a stepwise approach based on symptom control, exacerbation frequency and inhaler technique. Current guidance favours inhaled corticosteroid-containing therapy as the controller backbone rather than reliever monotherapy.

Red flags

  • Frequent exacerbations or any life-threatening attack
  • Rising reliever use (more than monthly salbutamol inhalers)
  • Poor growth on high-dose steroids
  • Persistent symptoms despite good adherence and technique (consider alternative diagnosis)

Assessment

Differential diagnosis

  • Preschool viral/multi-trigger wheeze
  • Inhaled foreign body
  • Bronchiolitis or recurrent viral LRTI
  • Cystic fibrosis or primary ciliary dyskinesia
  • Dysfunctional breathing / vocal cord dysfunction
  • Cardiac or structural airway disease
  • Chronic cough from other cause (e.g. protracted bacterial bronchitis)

Investigations

  • Diagnosis supported by history of variable wheeze/cough/breathlessness and response to treatment
  • Spirometry with bronchodilator reversibility in children able to perform (usually over 5)
  • FeNO where available to support eosinophilic inflammation
  • Peak flow diary in older children
  • Assess inhaler technique and adherence at each review
  • Allergy testing/chest X-ray only if diagnostic doubt or red flags

Management

  • Confirm diagnosis objectively where possible and identify triggers
  • Assess control (symptoms, reliever use, night waking, exacerbations, absence)
  • Check and correct inhaler technique and spacer use at every visit
  • Start/maintain regular inhaled corticosteroid-containing controller therapy
  • Step up (add LABA/LTRA or increase ICS) if control inadequate despite good technique/adherence
  • Consider ICS-formoterol maintenance-and-reliever regimens in suitable older children
  • Provide a written personalised asthma action plan
  • Address triggers, smoking exposure, allergen avoidance and vaccination
  • Step down therapy once stable; refer to specialist if uncontrolled on moderate-dose therapy

Drugs & doses

Inhaled corticosteroid via spacer, e.g. beclometasone 100-200 microgram twice daily (low paediatric dose), titrated to control
Montelukast 4 mg (2-5 yr) or 5 mg (6-14 yr) PO nocte as add-on controller
Salbutamol 100-200 microgram inhaled via spacer as reliever as required
ICS/formoterol combination inhaler for maintenance-and-reliever therapy in older children per step

Disposition

Primary care/paediatric outpatient with regular structured review; refer to specialist if uncontrolled on moderate therapy or diagnostic doubt.

Complications & pitfalls

  • Acute severe exacerbations and hospital admission
  • Growth suppression and adrenal effects from high-dose steroids
  • Fixed airflow limitation if poorly controlled
  • Reduced quality of life, school absence and exercise limitation

Exam pearls

  • Never treat asthma with short-acting reliever alone; an ICS-containing controller is the backbone
  • Over-reliance on salbutamol is a marker of poor control and risk
  • Most poor control is due to technique or adherence, not drug failure
  • Review and step down once stable to use the lowest effective dose

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.